Combining anti-cyclic citrullinated peptide with the American College of Rheumatology 1987 criteria failed to improve early rheumatoid arthritis diagnosis in the community-based very early arthritis cohort.

@article{Lot2011CombiningAC,
  title={Combining anti-cyclic citrullinated peptide with the American College of Rheumatology 1987 criteria failed to improve early rheumatoid arthritis diagnosis in the community-based very early arthritis cohort.},
  author={Xavier le Lo{\"e}t and Victor Strotz and Thierry Lequerr{\'e} and Patrick Boumier and Sophie Pouplin and Othmane Mejjad and Alain Daragon and Fabienne Jouen and Olivier Vittecoq and Patrice Fardellone and Jean-François M{\'e}nard},
  journal={Rheumatology},
  year={2011},
  volume={50 10},
  pages={1901-7}
}
OBJECTIVES To test the performances of combining anti-CCP second generation (CCP2) with ACR 1987 classification criteria and to diagnose early RA in a community-based very early arthritis (VErA) patient cohort. METHODS The VErA cohort comprised 310 patients (median age 52 years; 68.1% women; median symptom duration 4.2 months; glucocorticoid- and DMARD na… CONTINUE READING